Literature DB >> 9116244

beta-Amyloid induction of gelatinase B secretion in cultured microglia: inhibition by dexamethasone and indomethacin.

P E Gottschall1.   

Abstract

Since administration of anti-inflammatory drugs has been reported to possibly slow the progression of Alzheimer's disease, an effort was made to define effector functions induced by beta-amyloid (A beta) which may be inhibited by these drugs. Rat microglia in culture were treated with various A beta fragments and gelatinase (GLase) activity was determined using gelatin-substrate zymography; the ability of indomethacin (INDO) and dexamethasone (DEX) to inhibit A beta-stimulated GLase, specifically matrix metalloproteinase-9 (MMP-9), activity was also evaluated. A beta (1-38) and A beta (1-40) were effective in stimulating MMP-9 activity in a dose-dependent fashion. Co-treatment with INDO (50 microM) or DEX (100 nM) resulted in a 54% and 66% inhibition, respectively, of A beta (1-40)-stimulated MMP-9 production in microglia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9116244     DOI: 10.1097/00001756-199611250-00057

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

1.  Inflammation in neuroviral diseases.

Authors:  Pascale Giraudon; Arlette Bernard
Journal:  J Neural Transm (Vienna)       Date:  2010-08       Impact factor: 3.575

2.  Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw.

Authors:  Joanne M Ajmo; Lauren A Bailey; Matthew D Howell; Lisa K Cortez; Keith R Pennypacker; Hina N Mehta; Dave Morgan; Marcia N Gordon; Paul E Gottschall
Journal:  J Neurochem       Date:  2010-02-17       Impact factor: 5.372

3.  A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease.

Authors:  Sid E O'Bryant; Fan Zhang; Leigh A Johnson; James Hall; Melissa Edwards; Paula Grammas; Esther Oh; Constantine G Lyketsos; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1.

Authors:  Lisa A Ridnour; Sneha Dhanapal; Michael Hoos; Joan Wilson; Jennifer Lee; Robert Y S Cheng; Ernst E Brueggemann; Harry B Hines; Donna M Wilcock; Michael P Vitek; David A Wink; Carol A Colton
Journal:  J Neurochem       Date:  2012-10-25       Impact factor: 5.372

5.  Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy.

Authors:  Lingzhi Zhao; Michal Arbel-Ornath; Xueying Wang; Rebecca A Betensky; Steven M Greenberg; Matthew P Frosch; Brian J Bacskai
Journal:  Neurobiol Aging       Date:  2015-07-16       Impact factor: 4.673

Review 6.  Amyloid beta peptide-degrading microbial enzymes and its implication in drug design.

Authors:  Maruti J Dhanavade; Kailas D Sonawane
Journal:  3 Biotech       Date:  2020-05-11       Impact factor: 2.406

7.  Angiostrongylus cantonensis infection induces MMP-9 and causes tight junction protein disruption associated with Purkinje cell degeneration.

Authors:  Shih-Chan Lai; Cheng-You Lu; Ling-Yuh Shyu; Ke-Min Chen
Journal:  Parasitol Res       Date:  2020-08-13       Impact factor: 2.289

8.  Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia.

Authors:  E Vegeto; C Bonincontro; G Pollio; A Sala; S Viappiani; F Nardi; A Brusadelli; B Viviani; P Ciana; A Maggi
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

Review 9.  Latest Study on the Relationship between Pathological Process of Inflammatory Injury and the Syndrome of Spleen Deficiency and Fluid Retention in Alzheimer's Disease.

Authors:  Beibei Yu; Chunxiang Zhou; Jiangyuan Zhang; Yun Ling; Qianfeng Hu; Yi Wang; Kangkang Bai
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-03       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.